METASTATIC HORMONE-SENSITIVE PROSTATE CANCE
Clinical trials for METASTATIC HORMONE-SENSITIVE PROSTATE CANCE explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE-SENSITIVE PROSTATE CANCE trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new drug combo aims to tackle Hard-to-Treat prostate cancer
Disease control Not yet recruitingThis phase II pilot trial is testing a three-drug combination—radium-223, darolutamide, and standard hormone therapy—in men with high-volume metastatic hormone-sensitive prostate cancer. The goal is to see if adding radium-223 as maintenance therapy after initial treatment can im…
Matched conditions: METASTATIC HORMONE-SENSITIVE PROSTATE CANCE
Phase: PHASE2 • Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New study aims to unlock secrets of prostate cancer treatment resistance
Knowledge-focused Not yet recruitingThis study will follow 396 men with metastatic hormone-sensitive prostate cancer to understand how the disease changes over time and becomes resistant to therapy. Participants receive standard treatments like abiraterone plus hormone therapy, and researchers will analyze genetic …
Matched conditions: METASTATIC HORMONE-SENSITIVE PROSTATE CANCE
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:21 UTC